These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 25853291)
1. The effects of the frequency of the initial treatment with intravitreal bevacizumab on macular volume and visual acuity. Segal O; Mimouni M; Nemet AY; Segev F; Geffen N; Nesher R J Ocul Pharmacol Ther; 2015 Jun; 31(5):277-81. PubMed ID: 25853291 [TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration. Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A Retina; 2007; 27(4):432-8. PubMed ID: 17420694 [TBL] [Abstract][Full Text] [Related]
3. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up. Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA; Retina; 2008; 28(10):1387-94. PubMed ID: 18827735 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687 [TBL] [Abstract][Full Text] [Related]
5. Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study. Saviano S; Leon PE; Mangogna A; Tognetto D Digit J Ophthalmol; 2016; 22(2):46-53. PubMed ID: 27582675 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy. Rush RB; Rush SW; Aragon AV; Ysasaga JE Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study. Arevalo JF; Sánchez JG; Wu L; Berrocal MH; Alezzandrini AA; Restrepo N; Maia M; Farah ME; Brito M; Díaz-Llopis M; Rodríguez FJ; Reategui G; Iturralde-Iraola J; Udaondo-Mirete P; Ophthalmology; 2010 Oct; 117(10):1974-81, 1981.e1. PubMed ID: 20569989 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Emerson MV; Lauer AK; Flaxel CJ; Wilson DJ; Francis PJ; Stout JT; Emerson GG; Schlesinger TK; Nolte SK; Klein ML Retina; 2007; 27(4):439-44. PubMed ID: 17420695 [TBL] [Abstract][Full Text] [Related]
16. Induction with intravitreal bevacizumab every two weeks in the management of neovascular age-related macular degeneration. Barikian A; Mahfoud Z; Abdulaal M; Safar A; Bashshur ZF Am J Ophthalmol; 2015 Jan; 159(1):131-7. PubMed ID: 25308787 [TBL] [Abstract][Full Text] [Related]
17. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections. Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration. Ladas ID; Chatziralli IP; Kotsolis AI; Douvali M; Georgalas I; Theodossiadis PG; Rouvas AA Ophthalmologica; 2012; 228(2):93-101. PubMed ID: 22571933 [TBL] [Abstract][Full Text] [Related]
19. Short-term effectiveness of intravitreal bevacizumab versus ranibizumab injections for patients with neovascular age-related macular degeneration. Chang TS; Kokame G; Casey R; Prenner J; Feiner L; Anderson N Retina; 2009 Oct; 29(9):1235-41. PubMed ID: 19934818 [TBL] [Abstract][Full Text] [Related]
20. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Rich RM; Rosenfeld PJ; Puliafito CA; Dubovy SR; Davis JL; Flynn HW; Gonzalez S; Feuer WJ; Lin RC; Lalwani GA; Nguyen JK; Kumar G Retina; 2006; 26(5):495-511. PubMed ID: 16770255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]